Efficacy of Low-glycemic Index Medical Food on Satiety

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20211111003

Enrollment

Registered

2021-11-11

Start date

2019-03-12

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Low glycemic index medical food Gut hormone Satiety

Interventions

Low GI medical food , 300 ml (327.33 kcal) was served for breakfast. ,Soybean milk, 300 ml (327.33 kcal) was served for breakfast as control diet

Experimental Dietary Supplement,Placebo Comparator No treatment

Low glycemic index medical food,Soybean milk

Eligibility

Sex/Gender

All

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Normal weight and obesity adults (10 males and 10 females per group) which classified by percentage of body fat. 2. Subjects who used not of medicine or weight loss supplements 3. Subjects who had no medical history of gastritis or use of antacid

Exclusion criteria

Exclusion criteria: Liver disease, kidney disease, thyroid disease, anemia and infectious disease

Design outcomes

Primary

Measure	Time frame
Gut hormones (Plasma GLP-1, ghrelin, and total PYY ) baseline, 30, 60, 120, and 240 minutes after breakfast Milliplex MAP kits	—

Secondary

Measure	Time frame
Satiety before, 30, 60, 90, 120, 150, 180, 210, and 240 minutes after each breakfast Visual analog scale,Buffet lunch intake The end of study (240 min later after breakfast) record	—

Countries

Thailand

Contacts

Public ContactRattikan Sumpao

Graduate student in Master of Science Program in Nutrition, Faculty of Medicine Ramathibodi Hospital and Institute of Nutrition, Mahidol University

rattikan2643@gmail.com0998173762

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026